Trial Profile
A Randomized, Open-Label, Single-Centre,Three-Way Crossover Study to Assess the Effect of Food and Formulation on the Bioavailability of TRC4186 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Aug 2009
Price :
$35
*
At a glance
- Drugs TRC 4186 (Primary)
- Indications Cardiovascular disorders; Diabetic complications
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Torrent Pharmaceuticals
- 01 Sep 2009 Results published in Clinical Drug Investigation.
- 12 Aug 2009 New trial record.